2022 Q1 Form 10-Q Financial Statement

#000165495422006492 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2021
Revenue $10.44M $15.22M $50.64M
YoY Change -31.43% 54.81% 15.46%
Cost Of Revenue $8.787M $9.496M $36.22M
YoY Change -7.47% 15.38% 10.37%
Gross Profit $1.648M $5.722M $14.42M
YoY Change -71.2% 257.63% 30.59%
Gross Profit Margin 15.79% 37.6% 28.47%
Selling, General & Admin $1.821M $1.920M $8.252M
YoY Change -5.16% 17.07% 13.3%
% of Gross Profit 110.5% 33.55% 57.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $703.0K $646.0K $2.671M
YoY Change 8.82% 13.33% 10.74%
% of Gross Profit 42.66% 11.29% 18.52%
Operating Expenses $1.821M $1.920M $8.252M
YoY Change -5.16% 17.07% 13.3%
Operating Profit -$173.0K $3.802M $6.168M
YoY Change -104.55% -9605.0% 64.09%
Interest Expense $48.00K $42.00K $190.0K
YoY Change 14.29% -184.0% -12.44%
% of Operating Profit 1.1% 3.08%
Other Income/Expense, Net $20.00K -$7.000K $2.926M
YoY Change -385.71% 8766.67%
Pretax Income -$159.0K $3.808M $9.094M
YoY Change -104.18% -7716.0% 139.82%
Income Tax -$40.00K $940.0K $1.524M
% Of Pretax Income 24.68% 16.76%
Net Earnings -$119.0K $2.867M $7.570M
YoY Change -104.15% -7644.74% 184.05%
Net Earnings / Revenue -1.14% 18.84% 14.95%
Basic Earnings Per Share -$0.02 $1.45
Diluted Earnings Per Share -$22.75K $550.9K $1.45
COMMON SHARES
Basic Shares Outstanding 5.230M shares 5.202M shares 5.205M shares
Diluted Shares Outstanding 5.230M shares 5.210M shares 5.210M shares

Balance Sheet

Concept 2022 Q1 2021 Q1 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.82M $13.76M $13.49M
YoY Change 7.69% 309.52% 35.06%
Cash & Equivalents $14.82M $12.53M $13.49M
Short-Term Investments $1.230M $0.00
Other Short-Term Assets $443.0K $530.0K $551.0K
YoY Change -16.42% -25.35% -11.13%
Inventory $3.325M $2.350M $2.845M
Prepaid Expenses
Receivables $12.05M $11.72M $10.45M
Other Receivables $411.0K $0.00 $411.0K
Total Short-Term Assets $31.51M $28.36M $27.75M
YoY Change 11.1% 65.85% 18.9%
LONG-TERM ASSETS
Property, Plant & Equipment $21.63M $22.56M $25.32M
YoY Change -4.11% -1.31% 10.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $260.0K $300.0K $258.0K
YoY Change -13.33% -11.76% -19.38%
Total Long-Term Assets $25.06M $22.85M $25.57M
YoY Change 9.68% -1.51% 10.42%
TOTAL ASSETS
Total Short-Term Assets $31.51M $28.36M $27.75M
Total Long-Term Assets $25.06M $22.85M $25.57M
Total Assets $56.57M $51.21M $53.33M
YoY Change 10.47% 27.07% 14.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.525M $2.570M $2.071M
YoY Change 37.16% -3.75% 10.75%
Accrued Expenses $292.0K $2.140M $1.782M
YoY Change -86.36% 127.66% -21.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $607.0K $1.400M $468.0K
YoY Change -56.64% 64.71% -36.76%
Total Short-Term Liabilities $14.57M $11.68M $13.91M
YoY Change 24.73% 51.1% 56.28%
LONG-TERM LIABILITIES
Long-Term Debt $6.261M $6.040M $3.724M
YoY Change 3.66% 29.61% -45.95%
Other Long-Term Liabilities $2.023M $4.480M $1.987M
YoY Change -54.84% -14.67% -56.8%
Total Long-Term Liabilities $8.284M $10.52M $5.711M
YoY Change -21.25% 6.16% -50.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.57M $11.68M $13.91M
Total Long-Term Liabilities $8.284M $10.52M $5.711M
Total Liabilities $24.81M $24.65M $21.58M
YoY Change 0.66% 26.22% -5.58%
SHAREHOLDERS EQUITY
Retained Earnings $24.75M
YoY Change
Common Stock $53.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $102.0K
YoY Change
Treasury Stock Shares 40.92K shares
Shareholders Equity $31.76M $26.56M $31.75M
YoY Change
Total Liabilities & Shareholders Equity $56.57M $51.21M $53.33M
YoY Change 10.47% 27.07% 14.68%

Cashflow Statement

Concept 2022 Q1 2021 Q1 2021
OPERATING ACTIVITIES
Net Income -$119.0K $2.867M $7.570M
YoY Change -104.15% -7644.74% 184.05%
Depreciation, Depletion And Amortization $703.0K $646.0K $2.671M
YoY Change 8.82% 13.33% 10.74%
Cash From Operating Activities -$1.193M $4.302M $9.126M
YoY Change -127.73% 241.43% 21.89%
INVESTING ACTIVITIES
Capital Expenditures $196.0K $376.0K $5.367M
YoY Change -47.87% -156.12% 104.3%
Acquisitions
YoY Change
Other Investing Activities $39.00K $40.00K $1.713M
YoY Change -2.5% 33.33% 715.71%
Cash From Investing Activities -$157.0K -$337.0K -$3.654M
YoY Change -53.41% -47.34% 50.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $129.0K
YoY Change
Cash From Financing Activities $2.676M -$195.0K -$744.0K
YoY Change -1472.31% -192.86% -131.88%
NET CHANGE
Cash From Operating Activities -$1.193M $4.302M $9.126M
Cash From Investing Activities -$157.0K -$337.0K -$3.654M
Cash From Financing Activities $2.676M -$195.0K -$744.0K
Net Change In Cash $1.326M $3.770M $4.728M
YoY Change -64.83% 354.22% -36.11%
FREE CASH FLOW
Cash From Operating Activities -$1.193M $4.302M $9.126M
Capital Expenditures $196.0K $376.0K $5.367M
Free Cash Flow -$1.389M $3.926M $3.759M
YoY Change -135.38% 103.42% -22.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5229658 shares
CY2022Q1 us-gaap Cash
Cash
14818000 USD
CY2021Q4 us-gaap Cash
Cash
13492000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
467000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
437000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12047000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10013000 USD
CY2022Q1 smid Trade Unbilled
TradeUnbilled
463000 USD
CY2021Q4 smid Trade Unbilled
TradeUnbilled
439000 USD
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
1194000 USD
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1143000 USD
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2131000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1702000 USD
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
411000 USD
CY2022Q1 us-gaap Prepaid Taxes
PrepaidTaxes
411000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
443000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
551000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
31507000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
27751000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21632000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21926000 USD
CY2022Q1 us-gaap Deferred Costs
DeferredCosts
3171000 USD
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
3390000 USD
CY2022Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2383000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2454000 USD
CY2022Q1 smid Accrued Compensation Current
AccruedCompensationCurrent
907000 USD
CY2021Q4 smid Accrued Compensation Current
AccruedCompensationCurrent
1036000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
260000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
258000 USD
CY2022Q1 us-gaap Assets
Assets
56570000 USD
CY2021Q4 us-gaap Assets
Assets
53325000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3525000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2071000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
292000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
657000 USD
CY2022Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
1990000 USD
CY2021Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
2033000 USD
CY2022Q1 us-gaap Sale Leaseback Transaction Deferred Gain Net
SaleLeasebackTransactionDeferredGainNet
3462000 USD
CY2021Q4 us-gaap Sale Leaseback Transaction Deferred Gain Net
SaleLeasebackTransactionDeferredGainNet
3776000 USD
CY2022Q1 smid Operating Lease Liabilities Assets
OperatingLeaseLiabilitiesAssets
91000 USD
CY2021Q4 smid Operating Lease Liabilities Assets
OperatingLeaseLiabilitiesAssets
89000 USD
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
607000 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
468000 USD
CY2022Q1 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
1312000 USD
CY2021Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
1325000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14569000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13909000 USD
CY2022Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1925000 USD
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1865000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
98000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
122000 USD
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
6261000 USD
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3724000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1960000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1955000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
24813000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
21575000 USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5353095 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5353095 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5229658 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5229658 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
53000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
53000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7061000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6935000 USD
CY2021Q1 smid Product Sales
ProductSales
7420000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1325000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
40920 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
102000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
102000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
24745000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
24864000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
31757000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
31750000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56570000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53325000 USD
CY2022Q1 smid Product Sales
ProductSales
5851000 USD
CY2022Q1 smid Barrier Rentals
BarrierRentals
1485000 USD
CY2021Q1 smid Barrier Rentals
BarrierRentals
5777000 USD
CY2022Q1 smid Royalty Income
RoyaltyIncome
427000 USD
CY2021Q1 smid Royalty Income
RoyaltyIncome
420000 USD
CY2022Q1 smid Shipping And Installation Revenue
ShippingAndInstallationRevenue
2672000 USD
CY2021Q1 smid Shipping And Installation Revenue
ShippingAndInstallationRevenue
1601000 USD
CY2022Q1 us-gaap Revenues
Revenues
10435000 USD
CY2021Q1 us-gaap Revenues
Revenues
15218000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
8787000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
9496000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
1648000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
5722000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1159000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
662000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
595000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1821000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
1920000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-173000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3802000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
48000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
42000 USD
CY2022Q1 us-gaap Interest Income Domestic Deposits
InterestIncomeDomesticDeposits
3000 USD
CY2021Q1 us-gaap Interest Income Domestic Deposits
InterestIncomeDomesticDeposits
9000 USD
CY2022Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
39000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
46000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-159000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3808000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
40000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-941000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-119000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2867000 USD
CY2022Q1 smid Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.02
CY2021Q1 smid Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
0.55
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5230000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5202000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5230000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5210000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
31750000 USD
CY2022Q1 smid Restricted Stock Issued
RestrictedStockIssued
0 USD
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
126000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-119000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
31757000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23649000 USD
CY2021Q1 smid Restricted Stock Issued
RestrictedStockIssued
0 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
41000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3770000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
126000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
41000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
4000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2064000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1124000 USD
CY2022Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
24000 USD
CY2021Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
59000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
480000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2867000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
26557000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
119000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2867000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
703000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
646000 USD
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
39000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
46000 USD
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-8000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
30000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
153000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-90000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-104000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1454000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
701000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-365000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-211000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-11000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
521000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-129000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
69000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-43000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
959000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
314000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
301000 USD
CY2022Q1 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-13000 USD
CY2021Q1 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
284000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1193000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4302000 USD
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
7000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
196000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
376000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Other Property Plant And Equipment
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
39000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Other Property Plant And Equipment
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
46000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-157000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-337000 USD
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2805000 USD
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2022Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
129000 USD
CY2021Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
195000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2676000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1326000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13492000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8764000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14818000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12534000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
48000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
42000 USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><em>Major Customers</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">One customer accounted for 15% of revenues for the three month period ended March 31, 2022. Two customers accounted for 45% of revenues for the three month period ended March 31, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><em>Major Suppliers</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">No vendor accounted for more than 10% of purchases for the three month period ended March 31, 2022 or for fiscal year 2021.</p>
CY2022Q1 us-gaap Property Management Fee Percent Fee
PropertyManagementFeePercentFee
0.10 pure
CY2022Q1 us-gaap Reclassifications
Reclassifications
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Certain minor reclassifications have been made to prior year amounts to conform to the current year’s presentation.</p>
CY2022Q1 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
5230000 shares
CY2021 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
5202000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5230000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5210000 shares
CY2022Q1 smid Capital Expenditures Line Of Credit In Excess Amount
CapitalExpendituresLineOfCreditInExcessAmount
5000000 USD
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
12.45
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
12.45
CY2022Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
5000 shares

Files In Submission

Name View Source Status
0001654954-22-006492-index-headers.html Edgar Link pending
0001654954-22-006492-index.html Edgar Link pending
0001654954-22-006492.txt Edgar Link pending
0001654954-22-006492-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smid-20220331.xsd Edgar Link pending
smid-20220331_cal.xml Edgar Link unprocessable
smid-20220331_def.xml Edgar Link unprocessable
smid-20220331_lab.xml Edgar Link unprocessable
smid-20220331_pre.xml Edgar Link unprocessable
smid_10q.htm Edgar Link pending
smid_10q_htm.xml Edgar Link completed
smid_ex311.htm Edgar Link pending
smid_ex312.htm Edgar Link pending
smid_ex321.htm Edgar Link pending